Literature DB >> 8816502

Functional interaction between DP-1 and p53.

T S Sørensen1, R Girling, C W Lee, J Gannon, L R Bandara, N B La Thangue.   

Abstract

The cellular transcription factor DRTF1/E2F and the tumor suppressor protein p53 play important roles in controlling early cell cycle events. DRTF1/E2F is believed to coordinate and integrate the transcription of cell cycle-regulating genes, for example, those involved in DNA synthesis, with the activity of regulatory proteins, such as the retinoblastoma tumor suppressor gene product (pRb), which modulate its transcriptional activity. In contrast, p53 is thought to monitor the integrity of chromosomal DNA and when appropriate interfere with cell cycle progression, for example, in response to DNA damage. Generic DRTF1/E2F DNA binding activity and transcriptional activation arise when members of two distinct families of proteins, such as DP-1 and E2F-1, interact as DP/E2F heterodimers. In many cell types, DP-1 is a widespread component of DRTF1/E2F DNA binding activity which when expressed at high levels oncogenically transforms embryonic fibroblasts. Here, we document an association between DP-1 and p53 and demonstrate its presence in mammalian cell extracts. In vitro p53 interacts with an immunochemically distinct form of DP-1 and in vivo can regulate transcription driven by the DP-1/E2F-1 heterodimer. At the biochemical level, p53 competes with E2F-1 for DP-1, with a consequent reduction in DNA binding activity. Mutational analysis defines within DP-1 a C-terminal region required for the interaction with p53 and within p53 an N-terminal region distinct from that required to bind to MDM2. Our results establish DRTF1/E2F as a common cellular target in growth control mediated through the activities of pRb and p53 and suggest an alternative mechanism through which p53 may regulate cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816502      PMCID: PMC231590          DOI: 10.1128/MCB.16.10.5888

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

Authors:  M Mudryj; S H Devoto; S W Hiebert; T Hunter; J Pines; J R Nevins
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

6.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.

Authors:  S Shirodkar; M Ewen; J A DeCaprio; J Morgan; D M Livingston; T Chittenden
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

8.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

Authors:  S H Devoto; M Mudryj; J Pines; T Hunter; J R Nevins
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

9.  Cyclin A and the retinoblastoma gene product complex with a common transcription factor.

Authors:  L R Bandara; J P Adamczewski; T Hunt; N B La Thangue
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

10.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  17 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

3.  Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.

Authors:  D S Park; E J Morris; R Bremner; E Keramaris; J Padmanabhan; M Rosenbaum; M L Shelanski; H M Geller; L A Greene
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

4.  p53 is a general repressor of RNA polymerase III transcription.

Authors:  C A Cairns; R J White
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.

Authors:  Jung-Kuang Hsieh; Damian Yap; Daniel J O'Connor; Valentina Fogal; Lynn Fallis; Florence Chan; Shan Zhong; Xin Lu
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  Next-generation sequencing of colorectal cancers in chinese: identification of a recurrent frame-shift and gain-of-function Indel mutation in the TFDP1 gene.

Authors:  Chen Chen; Jie Liu; Fan Zhou; Jianbo Sun; Lisha Li; Chengmeng Jin; Jiaofang Shao; Huawei Jiang; Na Zhao; Shu Zheng; Biaoyang Lin
Journal:  OMICS       Date:  2014-08-18

7.  Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals.

Authors:  S Wang; N Nath; G Fusaro; S Chellappan
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

9.  Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.

Authors:  Martin C Abba; Victoria T Fabris; Yuhui Hu; Frances S Kittrell; Wei-Wen Cai; Lawrence A Donehower; Aysegul Sahin; Daniel Medina; C Marcelo Aldaz
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

10.  E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin.

Authors:  Korakod Chimploy; G Dario Díaz; Qingjie Li; Orianna Carter; Wan-Mohaiza Dashwood; Christopher K Mathews; David E Williams; George S Bailey; Roderick H Dashwood
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.